AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,362.00p
   
  • Change Today:
      22.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.67m
  • Volume: 2,456,281
  • Market Cap: £160,680m
  • RiskGrade: 123

Latest ShareCast News

Berenberg raises target price on AstraZeneca

By Iain Gilbert

Date: Wednesday 09 Jul 2025

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker AstraZeneca from £140 to £142 per share on Wednesday, citing "strong pipeline readouts" which were yet to be reflected in its share price.

AstraZeneca ShareCast News

Sunday newspaper round-up: Trade, AstraZeneca, T... 06-Jul-2025 ShareCast
London close: FTSE finishes flat ahead of Trump ... 04-Jul-2025 ShareCast
AstraZeneca's Imfinzi gets EU green light 04-Jul-2025 ShareCast
AstraZeneca's Datroway gets green light from FDA 24-Jun-2025 ShareCast
AstraZeneca launches strategic research collabor... 13-Jun-2025 ShareCast

AstraZeneca Regulatory News

Imfinzi approved in the EU for bladder cancer 04-Jul-2025 07:00 RNS
Total Voting Rights 01-Jul-2025 15:00 RNS
Datroway approved in US for EGFRm lung cancer 24-Jun-2025 07:00 RNS
Holding(s) in Company 17-Jun-2025 11:45 RNS
AstraZeneca enters into collaboration with CSPC 13-Jun-2025 09:30 RNS

AstraZeneca Newspaper Links

AstraZeneca CEO wants to move listing to the US 02-Jul-2025 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,362.00p
Change Today 22.00p
% Change 0.21 %
52 Week High 13,276.00p
52 Week Low 9,667.00p
Volume 2,456,281
Shares Issued 1,550.67m
Market Cap £160,680m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.58% below the market average93.58% below the market average93.58% below the market average93.58% below the market average93.58% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Price Trend
30.19% below the market average30.19% below the market average30.19% below the market average30.19% below the market average30.19% below the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average
Income
60.22% below the market average60.22% below the market average60.22% below the market average60.22% below the market average60.22% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
87.24% above the market average87.24% above the market average87.24% above the market average87.24% above the market average87.24% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 1
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 09-Jul-2025

Time Volume / Share Price
14:51 0 @ 10,320.00p
14:46 0 @ 10,298.00p
14:46 0 @ 10,298.00p
14:46 0 @ 10,298.00p
14:46 0 @ 10,298.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page